Cargando…

High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease

Coronavirus disease 2019 (COVID-19) in patients with severe impairment of kidney function is associated with high mortality. We evaluated the effect of high dependency renal unit (HDRU), with nephrologists as primary care physicians, as a quality improvement initiative for the management of these pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakare, Sayali, Modi, Tulsi, Gandhi, Chintan, Bose, Sreyashi, Deb, Satarupa, Katyal, Abhinav, Saxena, Nikhil, Patil, Ankita, Patil, Sunil, Pajai, Atim, Bajpai, Divya, Jadhav, Pratap, Jamale, Tukaram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439625/
https://www.ncbi.nlm.nih.gov/pubmed/36107561
http://dx.doi.org/10.1097/MD.0000000000030423
_version_ 1784782105178275840
author Thakare, Sayali
Modi, Tulsi
Gandhi, Chintan
Bose, Sreyashi
Deb, Satarupa
Katyal, Abhinav
Saxena, Nikhil
Patil, Ankita
Patil, Sunil
Pajai, Atim
Bajpai, Divya
Jadhav, Pratap
Jamale, Tukaram
author_facet Thakare, Sayali
Modi, Tulsi
Gandhi, Chintan
Bose, Sreyashi
Deb, Satarupa
Katyal, Abhinav
Saxena, Nikhil
Patil, Ankita
Patil, Sunil
Pajai, Atim
Bajpai, Divya
Jadhav, Pratap
Jamale, Tukaram
author_sort Thakare, Sayali
collection PubMed
description Coronavirus disease 2019 (COVID-19) in patients with severe impairment of kidney function is associated with high mortality. We evaluated the effect of high dependency renal unit (HDRU), with nephrologists as primary care physicians, as a quality improvement initiative for the management of these patients. This was a quasi-experimental observational study conducted at a tertiary care hospital in western India. Patients hospitalized for COVID-19 with pre-existing end-stage-renal-disease and those with severe AKI requiring dialysis (AKI-D) were included. For the first 2 months, these patients were cared for in medical wards designated for COVID-19, after which HDRU was set up for their management. With nephrologists as primary care providers, the 4 key components of care in HDRU included: care bundles focusing on key nephrology and COVID-19 related issues, checklist-based clinical monitoring, integration of multi-specialty care, and training of nurses and doctors. Primary outcome of the study was in-hospital mortality before and after institution of the HDRU care. Secondary outcomes were dialysis dependence in AKI-D and predictors of death. A total of 238 out of 4254 (5.59%) patients with COVID-19, admitted from 28th March to 30th September 2020, had severe renal impairment (116 AKI-D and 122 end-stage-renal-disease). 145 (62%) had severe COVID-19. From 28th May to 31st August 2020, these patients were managed in HDRU. Kaplan–Meier analysis showed significant improvement in survival during HDRU care [19 of 52 (36.5%) in pre-HDRU versus 35 of 160 (21.9%) in HDRU died, P ≤ .01]. 44 (67.7%) AKI-D survivors were dialysis dependent at discharge. Breathlessness and altered mental status at presentation, development of shock during hospital stay, and leukocytosis predicted mortality. HDRU managed by nephrologists is a feasible and potentially effective approach to improve the outcomes of patients with COVID-19 and severe renal impairment.
format Online
Article
Text
id pubmed-9439625
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94396252022-09-06 High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease Thakare, Sayali Modi, Tulsi Gandhi, Chintan Bose, Sreyashi Deb, Satarupa Katyal, Abhinav Saxena, Nikhil Patil, Ankita Patil, Sunil Pajai, Atim Bajpai, Divya Jadhav, Pratap Jamale, Tukaram Medicine (Baltimore) Research Article Coronavirus disease 2019 (COVID-19) in patients with severe impairment of kidney function is associated with high mortality. We evaluated the effect of high dependency renal unit (HDRU), with nephrologists as primary care physicians, as a quality improvement initiative for the management of these patients. This was a quasi-experimental observational study conducted at a tertiary care hospital in western India. Patients hospitalized for COVID-19 with pre-existing end-stage-renal-disease and those with severe AKI requiring dialysis (AKI-D) were included. For the first 2 months, these patients were cared for in medical wards designated for COVID-19, after which HDRU was set up for their management. With nephrologists as primary care providers, the 4 key components of care in HDRU included: care bundles focusing on key nephrology and COVID-19 related issues, checklist-based clinical monitoring, integration of multi-specialty care, and training of nurses and doctors. Primary outcome of the study was in-hospital mortality before and after institution of the HDRU care. Secondary outcomes were dialysis dependence in AKI-D and predictors of death. A total of 238 out of 4254 (5.59%) patients with COVID-19, admitted from 28th March to 30th September 2020, had severe renal impairment (116 AKI-D and 122 end-stage-renal-disease). 145 (62%) had severe COVID-19. From 28th May to 31st August 2020, these patients were managed in HDRU. Kaplan–Meier analysis showed significant improvement in survival during HDRU care [19 of 52 (36.5%) in pre-HDRU versus 35 of 160 (21.9%) in HDRU died, P ≤ .01]. 44 (67.7%) AKI-D survivors were dialysis dependent at discharge. Breathlessness and altered mental status at presentation, development of shock during hospital stay, and leukocytosis predicted mortality. HDRU managed by nephrologists is a feasible and potentially effective approach to improve the outcomes of patients with COVID-19 and severe renal impairment. Lippincott Williams & Wilkins 2022-09-02 /pmc/articles/PMC9439625/ /pubmed/36107561 http://dx.doi.org/10.1097/MD.0000000000030423 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle Research Article
Thakare, Sayali
Modi, Tulsi
Gandhi, Chintan
Bose, Sreyashi
Deb, Satarupa
Katyal, Abhinav
Saxena, Nikhil
Patil, Ankita
Patil, Sunil
Pajai, Atim
Bajpai, Divya
Jadhav, Pratap
Jamale, Tukaram
High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease
title High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease
title_full High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease
title_fullStr High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease
title_full_unstemmed High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease
title_short High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease
title_sort high dependency renal unit for the management of covid-19 in patients with severe acute or chronic kidney disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439625/
https://www.ncbi.nlm.nih.gov/pubmed/36107561
http://dx.doi.org/10.1097/MD.0000000000030423
work_keys_str_mv AT thakaresayali highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease
AT moditulsi highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease
AT gandhichintan highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease
AT bosesreyashi highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease
AT debsatarupa highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease
AT katyalabhinav highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease
AT saxenanikhil highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease
AT patilankita highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease
AT patilsunil highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease
AT pajaiatim highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease
AT bajpaidivya highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease
AT jadhavpratap highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease
AT jamaletukaram highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease